Table 3.

Prevalence of infection [n (%)] with α-HPV types and species in the Ludwig-McGill Cohort Study (n = 505)

Type-specific α-HPVPositivity at enrollmentPositivity at 1-year follow-upPositivity at enrollment and follow-upPositivity at enrollment or follow-up
HPV6/115 (0.99)005 (0.99)
HPV1619 (3.76)12 (2.38)6 (1.19)25 (4.95)
HPV183 (0.59)2 (0.40)05 (0.99)
HPV260000
HPV313 (0.59)5 (0.99)1 (0.20)7 (1.39)
HPV3201 (0.20)01 (0.20)
HPV331 (0.20)1 (0.20)02 (0.40)
HPV340000
HPV351 (0.20)1 (0.20)02 (0.40)
HPV3902 (0.40)02 (0.40)
HPV402 (0.40)2 (0.40)1 (0.20)3 (0.59)
HPV420000
HPV443 (0.59)2 (0.40)05 (0.99)
HPV4501 (0.20)01 (0.20)
HPV516 (1.19)5 (0.99)1 (0.20)10 (1.98)
HPV525 (0.99)4 (0.79)1 (0.20)8 (1.58)
HPV538 (1.58)7 (1.39)015 (2.97)
HPV542 (0.40)4 (0.79)1 (0.20)5 (0.99)
HPV561 (0.20)4 (0.79)1 (0.20)4 (0.79)
HPV570000
HPV584 (0.79)5 (0.99)1 (0.20)8 (1.58)
HPV592 (0.40)1 (0.20)03 (0.59)
HPV614 (0.79)4 (0.79)1 (0.20)7 (1.39)
HPV620000
HPV664 (0.79)1 (0.20)05 (0.99)
HPV670000
HPV6802 (0.40)02 (0.40)
HPV690000
HPV706 (1.19)2 (0.40)2 (0.40)6 (1.19)
HPV711 (0.20)4 (0.79)05 (0.99)
HPV7201 (0.20)01 (0.20)
HPV730000
HPV811 (0.20)1 (0.20)02 (0.40)
HPV821 (0.20)001 (0.20)
HPV8301 (0.20)01 (0.20)
HPV842 (0.40)2 (0.40)04 (0.79)
HPV890000
α-HPV speciesa
α-101 (0.20)01 (0.20)
α-37 (1.39)9 (1.78)1 (0.20)15 (2.97)
α-40000
α-57 (1.39)5 (0.99)1 (0.20)11 (2.18)
α-613 (2.57)12 (2.38)1 (0.20)24 (4.75)
α-711 (2.18)9 (1.78)2 (0.40)18 (3.56)
α-82 (0.40)2 (0.40)1 (0.20)3 (0.59)
α-932 (6.34)26 (5.15)9 (1.78)49 (9.70)
α-108 (1.58)2 (0.40)010 (1.98)
α-110000
α-132 (0.40)4 (0.79)1 (0.20)5 (0.99)
α-141 (0.20)4 (0.79)05 (0.99)
Any α-HPV69 (13.66)66 (13.07)26 (5.15)109 (21.58)
  • aα-HPV species: α-1 (HPVs 32, 42); α-3 (HPVs 61, 62, 72, 81, 83, 84, 89); α-4 (HPV57); α-5 (HPVs 26, 51, 69, 82); α-6 (HPVs 53, 56, 66); α-7 (HPVs 18, 39, 45, 59, 68, 70); α-8 (HPV40); α-9 (HPVs 16, 31, 33, 35, 52, 58, 67); α-10 (HPVs 6, 11, 44); α-11 (HPVs 34, 73); α-13 (HPV54); α-14 (HPV71).